Andrea Cercek, MD - Accelerating Personalized Care in CRC: The Prominent Role of Predictive Biomarkers and Immunotherapy Platforms in Early and Advanced Disease

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/JXZ865. CME/MOC/AAPA/IPCE credit will be available until November 7, 2025.

Accelerating Personalized Care in CRC: The Prominent Role of Predictive Biomarkers and Immunotherapy Platforms in Early and Advanced Disease

In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

SupportThis educational activity is supported by an independent medical education grant from GSK.

Disclosure information is available at the beginning of the video presentation.